VASCULAR BIOGENICS, created in 2008 (Israel), from 6 sister brands and 2214 competing brands. The VASCULAR BIOGENICS brand is owned by NOTABLE LABS, LTD., a company listed in New York. The International Securities Identification Number (ISIN) of NOTABLE LABS, LTD. is IL0011327454. VASCULAR BIOGENICS is part of the Biotechnology activity sector.

VASCULAR BIOGENICS is a brand of NOTABLE LABS, LTD. (NTBL) Share price

International deposit : 2008 Business sector Biotechnology

Share price and profitability of the share NOTABLE LABS, LTD. (VASCULAR BIOGENICS)

Buy NOTABLE LABS, LTD. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 0.98

Portfolio valuation
NOTABLE LABS, LTD. (VASCULAR BIOGENICS) over 5 years* USD 0.00

Stock market history NOTABLE LABS, LTD. (VASCULAR BIOGENICS)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
NOTABLE LABS, LTD.

NOTABLE LABS
NOTABLE LABS
VBL therapeutics
VBL therapeutics
See more brands of NOTABLE LABS, LTD.

Rival brands
VASCULAR BIOGENICS

Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
ZEVRA THERAPEUTICS
ZEVRA THERAPEUTICS
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS